These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

649 related items for PubMed ID: 24837362

  • 1. Menopause-specific quality of life across varying menopausal populations with conjugated estrogens/bazedoxifene.
    Abraham L, Pinkerton JV, Messig M, Ryan KA, Komm BS, Mirkin S.
    Maturitas; 2014 Jul; 78(3):212-8. PubMed ID: 24837362
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of bazedoxifene/conjugated estrogens on quality of life in postmenopausal women with symptoms of vulvar/vaginal atrophy.
    Bachmann G, Bobula J, Mirkin S.
    Climacteric; 2010 Apr; 13(2):132-40. PubMed ID: 19863455
    [Abstract] [Full Text] [Related]

  • 4. A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women.
    Kagan R, Williams RS, Pan K, Mirkin S, Pickar JH.
    Menopause; 2010 Mar; 17(2):281-9. PubMed ID: 19779382
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Bazedoxifene/conjugated estrogens for menopausal symptom treatment and osteoporosis prevention.
    Pinkerton JV, Pickar JH, Racketa J, Mirkin S.
    Climacteric; 2012 Oct; 15(5):411-8. PubMed ID: 22853444
    [Abstract] [Full Text] [Related]

  • 7. Direct and indirect effects of conjugated estrogens/bazedoxifene treatment on quality of life in postmenopausal women.
    Abraham L, Bushmakin AG, Dragon E, Komm BS, Pinkerton JV.
    Maturitas; 2016 Dec; 94():173-179. PubMed ID: 27823739
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Relationship between changes in vulvar-vaginal atrophy and changes in sexual functioning.
    Pinkerton JV, Bushmakin AG, Komm BS, Abraham L.
    Maturitas; 2017 Jun; 100():57-63. PubMed ID: 28539177
    [Abstract] [Full Text] [Related]

  • 13. Sleep parameters and health-related quality of life with bazedoxifene/conjugated estrogens: a randomized trial.
    Pinkerton JV, Pan K, Abraham L, Racketa J, Ryan KA, Chines AA, Mirkin S.
    Menopause; 2014 Mar; 21(3):252-9. PubMed ID: 23942245
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of efficacy and safety of conjugated estrogens/bazedoxifene in a Latin American population.
    Palacios S, Arias L, Lavenberg J, Pan K, Mirkin S, Komm BS.
    Climacteric; 2016 Jun; 19(3):261-7. PubMed ID: 26940720
    [Abstract] [Full Text] [Related]

  • 19. Effects of bazedoxifene/conjugated estrogens on endometrial safety and bone in postmenopausal women.
    Mirkin S, Komm BS, Pan K, Chines AA.
    Climacteric; 2013 Jun; 16(3):338-46. PubMed ID: 23038989
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.